Trials / Terminated
TerminatedNCT02544269
Hemodynamic Effect of Lumbosacral Plexus Blockade Versus Spinal Anesthesia
Surgical Anesthesia for Elective Hip Surgery - Hemodynamic Effect of Lumbosacral Plexus Blockade Compared to Spinal Anesthesia
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates the hemodynamic effect of lumbosacral plexus blockades versus spinal anesthesia for hip replacement. Half of participants will receive lumbosacral plexus blockade and the other half will receive continuous spinal anesthesia.
Detailed description
Patients for total hip replacement will be randomized for surgical anesthesia with either lumbosacral plexus blockade or continuous spinal anesthesia. All patients will receive central venous, arterial and spinal catheters. Hemodynamics will be monitored with transpulmonary thermodilution and pulse contour analysis. Perineural injection of study medicine around the lumbar and sacral plexus will be performed guided by ultrasound and nerve stimulation. Study medicine will be injected in divided doses in the spinal catheter. Treatment will be blinded using double-dummy technique. After the first intrathecal dose of study medicine, the hemodynamic response will be monitored for 60 minutes. Patients will then be transferred to the operating room, where total hip replacement will be performed in lumbosacral plexus blockade or spinal anesthesia according to randomization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ropivacaine | Lumbosacral plexus blockade with ropivacaine. |
| PROCEDURE | Bupivacaine | Regional anesthesia with bupivacaine titrated to the lowest effective dose |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-01-25
- Completion
- 2017-01-25
- First posted
- 2015-09-09
- Last updated
- 2017-05-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02544269. Inclusion in this directory is not an endorsement.